Literature DB >> 34039351

Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study.

Anxin Wang1,2, Xue Tian3,4, Yingting Zuo3,4, Shuohua Chen5, Xia Meng1,2, Shouling Wu6, Yongjun Wang7,8.   

Abstract

BACKGROUND: Previous studies has shown a significant relationship between baseline triglyceride-glucose (TyG) index and subsequent cardiovascular disease (CVD). However, the effect of longitudinal changes in TyG index on the risk of CVD remains uncertain. This study aimed to investigate the association between change in TyG index and the risk of CVD in the general population.
METHODS: The current study included 62,443 Chinese population who were free of CVD. The TyG index was calculated as ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2], and change in TyG index was defined as the difference between the TyG index in 2010 and that in 2006. Multivariable-adjusted Cox proportional hazard models and restricted cubic spline analysis were used to examine the association between change in TyG index and the risk of CVD.
RESULTS: During a median follow-up of 7.01 years, 2530 (4.05%) incident CVD occurred, including 2018 (3.23%) incident stroke and 545 (0.87%) incident myocardial infarction (MI). The risk of developing CVD increased with the quartile of change in TyG index, after adjustment for multiple potential confounders, the hazard ratios for the Q4 group versus the Q1 group were 1.37 (95% confidence interval [CI], 1.21-1.54) for the overall CVD, 1.38 (95% CI, 1.19-1.60) for stroke, and 1.36 (95% CI, 1.05-1.76) for MI. Restricted cubic spline analysis also showed a cumulative increase in the risk of CVD with increases in the magnitude of change in TyG index. The addition of change in TyG index to a baseline risk model for CVD improved the C-statistics (P = 0.0097), integrated discrimination improvement value (P < 0.0001), and category-free net reclassification improvement value (P < 0.0001). Similar results were observed for stroke and MI.
CONCLUSIONS: Substantial changes in TyG index independently predict the risk of CVD in the general population. Monitoring long-term changes in TyG may assist with in the early identification of individuals at high risk of CVD.

Entities:  

Keywords:  Cardiovascular disease; Longitudinal changes; Myocardial infarction; Predictive value; Stroke; Triglyceride-glucose index

Year:  2021        PMID: 34039351     DOI: 10.1186/s12933-021-01305-7

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  34 in total

1.  Temporal Relationship Between Hyperuricemia and Insulin Resistance and Its Impact on Future Risk of Hypertension.

Authors:  Tianshu Han; Li Lan; Rongge Qu; Qian Xu; Ruyue Jiang; Lixin Na; Changhao Sun
Journal:  Hypertension       Date:  2017-08-14       Impact factor: 10.190

2.  Lipid accumulation product and triglycerides/glucose index are useful predictors of insulin resistance.

Authors:  Mohsen Mazidi; Andre-Pascal Kengne; Niki Katsiki; Dimitri P Mikhailidis; Maciej Banach
Journal:  J Diabetes Complications       Date:  2017-10-21       Impact factor: 2.852

3.  Childhood social preference and adolescent insulin resistance: Accounting for the indirect effects of obesity.

Authors:  Meghan J Gangel; Jessica Dollar; Ashley Brown; Susan Keane; Susan D Calkins; Lilly Shanahan; Laurie Wideman
Journal:  Psychoneuroendocrinology       Date:  2019-12-23       Impact factor: 4.905

4.  Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.

Authors:  Isabel Huang-Doran; Patsy Tomlinson; Felicity Payne; Alexandra Gast; Alison Sleigh; William Bottomley; Julie Harris; Allan Daly; Nuno Rocha; Simon Rudge; Jonathan Clark; Albert Kwok; Stefano Romeo; Emma McCann; Barbara Müksch; Mehul Dattani; Stefano Zucchini; Michael Wakelam; Lazaros C Foukas; David B Savage; Rinki Murphy; Stephen O'Rahilly; Inês Barroso; Robert K Semple
Journal:  JCI Insight       Date:  2016-10-20

5.  Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study.

Authors:  Ângela Cristine Bersch-Ferreira; Geni Rodrigues Sampaio; Marcella Omena Gehringer; Elizabeth Aparecida Ferraz da Silva Torres; Maria Beatriz Ross-Fernandes; Jacqueline Tereza da Silva; Camila Ragne Torreglosa; Cristiane Kovacs; Renata Alves; Carlos Daniel Magnoni; Bernardete Weber; Marcelo Macedo Rogero
Journal:  Nutr J       Date:  2018-02-21       Impact factor: 3.271

6.  Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.

Authors:  Qi Zhao; Ting-Yu Zhang; Yu-Jing Cheng; Yue Ma; Ying-Kai Xu; Jia-Qi Yang; Yu-Jie Zhou
Journal:  Cardiovasc Diabetol       Date:  2020-07-08       Impact factor: 9.951

Review 7.  Association between insulin resistance and the development of cardiovascular disease.

Authors:  Valeska Ormazabal; Soumyalekshmi Nair; Omar Elfeky; Claudio Aguayo; Carlos Salomon; Felipe A Zuñiga
Journal:  Cardiovasc Diabetol       Date:  2018-08-31       Impact factor: 9.951

8.  Metabolic clustering of risk factors: evaluation of Triglyceride-glucose index (TyG index) for evaluation of insulin resistance.

Authors:  Sikandar Hayat Khan; Farah Sobia; Najmusaqib Khan Niazi; Syed Mohsin Manzoor; Nadeem Fazal; Fowad Ahmad
Journal:  Diabetol Metab Syndr       Date:  2018-10-05       Impact factor: 3.320

9.  Dietary antioxidant capacity and risk of type 2 diabetes mellitus, prediabetes and insulin resistance: the Rotterdam Study.

Authors:  Niels van der Schaft; Josje D Schoufour; Jana Nano; Jessica C Kiefte-de Jong; Taulant Muka; Eric J G Sijbrands; M Arfan Ikram; Oscar H Franco; Trudy Voortman
Journal:  Eur J Epidemiol       Date:  2019-08-09       Impact factor: 8.082

Review 10.  Assessment of pancreatic β-cell function: review of methods and clinical applications.

Authors:  Eugenio Cersosimo; Carolina Solis-Herrera; Michael E Trautmann; Jaret Malloy; Curtis L Triplitt
Journal:  Curr Diabetes Rev       Date:  2014-01
View more
  15 in total

1.  Evaluation of Persistent Efficacy of Diabetes Remission and Decline of Cardiovascular Risk After Laparoscopic Sleeve Gastrectomy: a Preliminary 1-Year Study.

Authors:  Yu-Min Huang; Weu Wang; Shu-Chen Wei; Pei-Fen Lee; Yi-Chiang Hsu; Wan-Ling Tu; Hsin-Hung Chen
Journal:  Obes Surg       Date:  2022-07-23       Impact factor: 3.479

2.  TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.

Authors:  Jianqi Zhao; Hongxuan Fan; Ting Wang; Bing Yu; Shaobin Mao; Xun Wang; Wenjing Zhang; Leigang Wang; Yao Zhang; Zhaoyu Ren; Bin Liang
Journal:  Cardiovasc Diabetol       Date:  2022-07-01       Impact factor: 8.949

3.  Triglyceride glucose index exacerbates the risk of future cardiovascular disease due to diabetes: evidence from the China Health and Retirement Longitudinal Survey (CHARLS).

Authors:  Zixiang Ye; Enmin Xie; Siqi Jiao; Yanxiang Gao; Peizhao Li; Yimin Tu; Ziyu Guo; Qing Li; Yaxin Wu; Xiaozhai Yu; Yike Li; Changan Yu; Jingyi Ren; Jingang Zheng
Journal:  BMC Cardiovasc Disord       Date:  2022-05-21       Impact factor: 2.174

4.  Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study.

Authors:  Haibin Li; Yingting Zuo; Frank Qian; Shuohua Chen; Xue Tian; Penglian Wang; Xia Li; Xiuhua Guo; Shouling Wu; Anxin Wang
Journal:  Cardiovasc Diabetol       Date:  2022-06-10       Impact factor: 8.949

5.  Relationship of cumulative exposure to the triglyceride-glucose index with ischemic stroke: a 9-year prospective study in the Kailuan cohort.

Authors:  Xianxuan Wang; Baoyu Feng; Zegui Huang; Zefeng Cai; Xinran Yu; Zekai Chen; Zhiwei Cai; Guanzhi Chen; Shouling Wu; Youren Chen
Journal:  Cardiovasc Diabetol       Date:  2022-05-03       Impact factor: 8.949

6.  Comparison of various insulin resistance surrogates on prognostic prediction and stratification following percutaneous coronary intervention in patients with and without type 2 diabetes mellitus.

Authors:  Qi Zhao; Yu-Jing Cheng; Ying-Kai Xu; Zi-Wei Zhao; Chi Liu; Tie-Nan Sun; Yu-Jie Zhou
Journal:  Cardiovasc Diabetol       Date:  2021-09-18       Impact factor: 9.951

7.  Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study.

Authors:  Yu Yan; Dan Wang; Yue Sun; Qiong Ma; Keke Wang; Yueyuan Liao; Chen Chen; Hao Jia; Chao Chu; Wenling Zheng; Jiawen Hu; Yue Yuan; Yang Wang; Yuliang Wu; Jianjun Mu
Journal:  Cardiovasc Diabetol       Date:  2022-02-25       Impact factor: 9.951

8.  Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study.

Authors:  Haozhe Cui; Qian Liu; Yuntao Wu; Liying Cao
Journal:  Cardiovasc Diabetol       Date:  2022-02-10       Impact factor: 9.951

9.  Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Shiqiang Xiong; Qiang Chen; Xu Chen; Jun Hou; Yingzhong Chen; Yu Long; Siqi Yang; Lingyao Qi; Hong Su; Wenchao Huang; Hanxiong Liu; Zhen Zhang; Lin Cai
Journal:  Cardiovasc Diabetol       Date:  2022-08-05       Impact factor: 8.949

10.  High triglyceride-glucose index in young adulthood is associated with incident cardiovascular disease and mortality in later life: insight from the CARDIA study.

Authors:  Xinghao Xu; Rihua Huang; Yifen Lin; Yue Guo; Zhenyu Xiong; Xiangbin Zhong; Xiaomin Ye; Miaohong Li; Xiaodong Zhuang; Xinxue Liao
Journal:  Cardiovasc Diabetol       Date:  2022-08-12       Impact factor: 8.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.